SHEN, WANG,BARR, KENNETH,OSLOB, JOHAN D.,ZHONG, MIN
申请号：
PL04810406
公开号：
PL1682537T3
申请日:
2004.11.05
申请国别(地区):
PL
年份:
2012
代理人:
摘要：
The present invention provides compounds having formula (I)； and pharmaceutically acceptable derivatives thereof, wherein R1-R4, n, p, A, B, D, E, L and AR1 are as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of disorders mediated by the CD11/CD18 family of cellular adhesion molecules (e.g., LFA-1).
